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Abstract 
Background: To assess the impact of a real-time random safety tool on structure, process and outcome indicators.
Methods: Prospective study conducted over a period of 12 months in two adult patient intensive care units. Safety 
rounds were conducted three days a week ascertaining 37 safety measures (grouped into 10 blocks). In each round, 
50% of the patients and 50% of the measures were randomized. The impact of this safety tool was analysed on indica-
tors of structure (safety culture, healthcare protocols), process (improvement proportion related to tool application, 
IPR) and outcome (mortality, average stay, rate of catheter-related bacteraemias and rate of ventilator-associated 
pneumonia, VAP).
Results: A total of 1214 patient-days were analysed. Structure indicators: the use of the safety tool was associated 
with an increase in the safety climate and the creation/modification of healthcare protocols (sedation/analgesia and 
weaning). Process indicators: Twelve of the 37 measures had an IPR > 10%; six showed a progressive decrease in the 
IPR over the study period. Nursing workloads and patient severity on the day of analysis were independently associ-
ated with a higher IPR in half of the blocks of variables. Outcome indicators: A significant decrease in the rate of VAP 
was observed.
Conclusions: The real-time random safety tool improved the care process and adherence to clinical practice guide-
lines and was associated with an improvement in structure, process and outcome indicators.
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Background
The application of evidence-based medicine is of major 
concern in intensive care medicine today [1]. Errors in 
health care may occur due to an unintended act or by 
omission. Those resulting from the former are more vis-
ible and therefore more easily detectable. Errors of omis-
sion are more insidious and more difficult to identify and 
include the failure to ensure that patients receive rec-
ommended medical care as supported by high-quality 
clinical research evidence [2], which occurs paradoxi-
cally in more severe patients [3]. For example, the lack 
of adherence to clinical practice guidelines may be due 
to the lack of knowledge about them and the presence of 
barriers that prevent their use such as a lack of time, a 
lack of resources, organizational aspects or even resist-
ance to changing work habits.
To analyse and prevent patient safety-related incidents, 
reactive or proactive tools are used. These are comple-
mentary to each other. Checklists have been proposed as 
a simple and useful proactive method to prevent errors 
of commission and omission in critically ill patients [4, 
5]. The complex reality in which they need to be imple-
mented requires an approach that includes more than 
eliminating barriers and supporting facilitating factors. 
Implementation leaders must facilitate team learning 
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to foster the mutual understanding of perspectives and 
motivations and the realignment of routines [6].
Among the various proactive methods, random safety 
audits [7] facilitate the interaction between the respon-
sible team and the professional who verifies the safety 
measures, and have the potential to reduce future errors 
through the identification of system failures that con-
tribute to gaps in quality and safety. This tool promotes 
the changes in accordance with the application of sci-
entific evidence, feedback with the team, and providing 
and strengthening knowledge [8]. Weiss et al. [9] showed 
that checklists of safety measures guided by an observer 
(prompter) decreased mortality and average length of 
stay in an intensive care unit (ICU) compared to those 
carried out through self-verification.
Our group has developed and validated a tool—the 
real-time random safety audits (in Spanish: Análisis Alea-
torios de Seguridad en Tiempo Real, AASTRE)—and 
found it to be effective in detecting and remedying errors 
of omission in real time, thereby improving adherence 
to guidelines [10] and proving to be most useful in situ-
ations of high care load and in more severe patients [11].
Thus, this multicentre study aims to investigate the 
usefulness of the AASTRE by measuring their effect on 
structure, process and outcome indicators.
Methods
Study design and participating centres
This is a prospective study involving two university hos-
pitals over a 1-year period (January–December 2013). 
Table 1 shows the characteristics of the two centres and 
the most relevant initiatives implemented in terms of 
patient safety.
Methodology for the implementation of the AASTRE
Design and description of the checklist
The checklist, as previously validated [10], consists of 37 
safety measures grouped into ten blocks of different areas of 
care: mechanical ventilation, haemodynamics, renal func-
tion and continuous renal replacement techniques (CRRT), 
sedation and analgesia, treatment (two blocks), nutrition, 
techniques and tests, nursing care and structure. AASTRE 
are standardly performed three days per week (including 
weeks with weekday holidays and holiday periods), with 
50% of the safety measures and 50% of the ICU patients ran-
domized on each day of analysis. Each safety measure has a 
specific definition, assessment criteria and a specific meth-
odology for verification. All patients admitted to the ICU are 
eligible for AASTRE to be performed on them. However, for 
each selected patient, only those measures for which they 
meet the assessment criteria will be evaluated [11].
Table 1 Characteristics of the centres and safety-related initiatives
No. absolute number, ICU intensive care unit, MV mechanical ventilation, AE adverse events, ENVIN (National Nosocomial Infections Surveillance Study), BZ 
Bacteremia Zero Spanish Project, NZ Pneumonia Zero Spanish Project, RZ Resistance Zero Spanish Project, VAP ventilator-associated pneumonia, CRB catheter-related 
bloodstream infection
Hospital 1 Hospital 2
No. of hospital beds 250 350
Teaching hospital
 Undergraduate Yes Yes
 Resident physician No Yes
No. of ICU beds
 Total at the centre 16 30
 ICU participating in study 16 14
Computerized ICU Yes Yes
Active protocol for:
 Sedation and analgesia No Yes
 Weaning No Yes
 Enteral nutrition Yes Yes
 Monitoring and MV alarms No No
Register of AE No No
Voluntary reporting of AE Yes Yes
ENVIN-ICU participation (BZ, NZ, RZ) Yes Yes
Other checklist systems (Not AASTRE) Prevention of VAP, CRB Prevention of VAP, CRB, intrahospital transfer
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Role and training of prompters
The safety audits are always carried out immediately after 
the ICU daily clinical round and require the participation of 
a prompter and the healthcare professionals directly respon-
sible for patient care (senior attending physician, residents 
and nurses). The prompter is one of the two senior attending 
physicians of each ICU (not directly caring for the patient) 
who has received the education and training required by the 
study and who is responsible for verifying and/or promoting 
the safety measures. At all centres, training sessions were 
held on the theoretical aspects and the methodology used in 
the AASTRE. In addition, all prompters were trained online 
in the goals of the study and in the use of the tool. Moreo-
ver, practical training was also required, carrying out at least 
three safety rounds prior to the start of the study.
Safety audits
Many of the measures included in the checklist are rou-
tinely carried out by healthcare professionals during the 
ICU daily clinical round. The purpose of the safety audits 
mate, safety climate, perceptions of management, 
job satisfaction, working conditions, and stress rec-
ognition. The questionnaire on the perception of 
safety culture was administered to medical, nursing 
and ancillary staff. Three evaluation periods were 
considered: 1) initial period: the month prior to the 
start of the study; 2) intermediate period: month 6 
of the study; 3) final period: the month after the end 
of the study.
•  The execution or updating of protocols and/or pro-
cedures promoted by the AASTRE was investigated.
3. Process indicators 
The proportion of changes in the care process carried 
out as a result of verification was considered. IPR-
AASTRE (improvement proportion related to the 
AASTRE) were calculated globally (IPR-AASTRE-G), 
for each safety measure (IPR-AASTRE), and for each 
block of variables (IPR-AASTRE-B), according to the 
following formulas:
is to verify that they have indeed been carried out. If 
this were not the case (error of omission), the prompter 
reminds the healthcare professionals that they should be 
carried out. In this framework, the possible responses 
during the audits are: (1) “Yes”—when the measure ana-
lysed had been taken/performed on the ICU daily round; 
(2) “Yes, after AASTRE”—when the safety audit was 
used to detect an error of omission that has been cor-
rected; (3) “No”—when the measure analysed could not 
be changed despite the audit; (4) “Not applicable”—when 
the patient did not meet the assessment criteria. The 
checklist and the responses of the evaluations are entered 
into a web platform (http://www.aastre.es). Safety audits 
were performed with a tablet at the bedside to facilitate 
implementation.
Definition of variables and indicators
1. Number of patient-days was the number of patients 
assessed in the total number of days on which safety 
audits were carried out in the two hospitals.
2. Structure indicators
•  Perception of safety culture (in Hospital 2): We 
used a previously validated questionnaire [12] 
based on the Safety Climate Survey (SCS) and the 
Safety Attitude Questionnaire-ICU model (SAQ-
ICU). It analysed six dimensions: teamwork cli-
IPR−AASTRE =
number ofoccasions on which the AASTRE changed clinical practice
(
"yes, after the AASTRE"
)
number of occasions on which the measure wasselected − number of occasions on which the measure wasnot applicable
×100
IPR−AASTRE−B =
sum of the number of occasions on which the AASTRE changed clinical practice in each block
number of occasions on which the measure was selected in each block− number of occasions on which the measure was not applicable in each block
×100
IPR-AASTRE-B helped simplify the assessment of 
the impact of other variables on utility. These varia-
bles are: type of patient (medical, surgical, neurocrit-
ical and trauma), staffing ratio [PNR; patient:nurse 
ratio (≤2:1 vs. >2:1) and PPR; patient:physician 
ratio (≤2:1, 2–3:1, >3:1)], the Sequential Organ Fail-
ure Assessment (SOFA) score and length of stay 
(length of stay at the time of safety audits (<7, 7–14, 
>14 days).
4. Outcome indicators 
The impact by the AASTRE on ICU mortality, aver-
age stay and rates of central venous catheter-related 
bacteraemia (CRB) and ventilator-associated pneu-
monia (VAP) using standardized definitions [13, 
14] was investigated. The clinical definition of VAP 
requires patients to fulfil one radiographic, one sys-
temic, and two pulmonary criteria. Radiographic cri-
teria include new or progressive infiltrates, consoli-
dation and cavitation. Systemic criteria include fever, 
abnormal white blood cell count and altered mental 
status. Pulmonary criteria include purulent sputum, 
new or worsening cough or dyspnoea or tachypnea, 
rales or bronchial breath sounds, and worsening gas 
exchange. CRB is defined in a patient with a central 
venous catheter with at least one positive blood cul-
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ture (two blood culture if common skin contaminant 
organism) obtained from a peripheral vein, clinical 
manifestations of infections (i.e. fever, chills and/or 
hypotension), and no apparent source for the blood-
stream infection except the catheter. One of the fol-
lowing should be present: a positive semi-quantita-
tive (>15 CFU per catheter segment) or quantitative 
(>102 CFU per catheter segment) catheter culture, 
whereby the same organism (species) is isolated 
from a catheter segment and a peripheral blood cul-
ture; simultaneous quantitative blood cultures with a 
ratio of >3:1  CFU/ml of blood (catheter vs. periph-
eral blood); differential time to positivity (growth in 
a culture of blood obtained through a catheter hub 
is detected by an automated blood culture system 
at least 2  h earlier than a culture of simultaneously 
drawn peripheral blood of equal volume). The infor-
mation relative to VAP and CRB was collected pro-
spectively at both centres participating in the study 
and the previous year, using identical diagnostic cri-
teria.
Statistical analysis
For descriptive analysis, we used absolute numbers (N) 
and relative frequency (percentage) for categorical vari-
ables; the mean and standard deviation for continuous 
variables. Chi-square tests and linear trend Chi-square 
tests were used for categorical variables and Student’s 
t test for continuous variables in univariate analysis. 
For multivariate analysis, multiple logistic regression, 
fixed model and likelihood ratio method analyses were 
performed to ascertain the impact of different variables 
on the IPR-AASTRE-B and with the aim of adjust-
ing for possible confounding effects. The results were 
expressed as odds ratio and their 95% confidence inter-
val (CI).
We used direct standardization by APACHE 2012 (<15, 
15–25, >25) to evaluate mortality change and incidence 
density ratio (IDR) 2013 vs 2012 and CI to evaluate CRB 
and VAP incidence changes. The acceptable level of sta-
tistical significance was set at p  ≤  0.05. All data analy-
ses were performed using the SPSS version 15 statistical 
package (SPSS Inc., Chicago, IL).
Table 2 Distribution of the type and severity of patient disease/condition, staffing ratios and length of stay on the day 
of evaluation
PNR patient:nurse ratio, PPR patient:physician ratio, SOFA Sequential Organ Failure Assessment
Global Hospital 1 Hospital 2 p
N % N % N %
Patient type <0.0001
 Medical 570 47.0 242 57.6 328 41.3
 Neurosurgery 118 9.7 12 2.9 106 13.4
 Surgical 397 32.7 146 34.8 251 31.6
 Traumatic 129 10.6 20 4.7 109 13.7
PNR <0.0001
 ≤ 2:1 787 64.8 16 3.8 771 97.1
 >2:1 427 35.2 404 96.2 23 2.9
PPR <0.0001
 ≤2:1 143 11.8 29 6.9 114 14.4
 2–3:1 756 62.3 240 57.1 516 65.0
 >3:1 315 25.9 151 36.0 164 20.6
SOFA 0.001
 <4 723 59.6 282 67.1 441 55.6
 4–7 357 29.3 97 23.1 260 32.7
 8–12 110 9.1 31 7.4 79 9.9
 ≥12 24 2.0 10 2.4 14 1.8
Length of stay <0.0001
 <7 532 43.8 227 54.0 305 38.4
 7–14 237 19.5 62 14.8 175 22.0
 14–21 146 12.0 29 6.9 117 14.8
 ≥21 299 24.7 102 24.3 197 24.8
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Results
During the study period, AASTRE were carried out on 
1214 patient-days. Table 2 shows the distribution of the 
type of patients evaluated globally, and in each hos-
pital, the workloads (of nursing staff and physicians), 
the seriousness of the patients measured using the 
SOFA and patients’ length of stay on the day the safety 
rounds were conducted. Most patients were medical 
(47.0%), with a PNR ≤2:1 (57.0%), a PPR 2–3:1(62.1%), 
SOFA <4 (56.9%) and an average stay <7 days (42.5%). 
It should be noted that the distribution of the types of 
patients evaluated is different in the two hospitals of 
the study. In Hospital 1, there was a predominance of 
medical patients (57.6%), followed by surgical patients 
(32.7%). In Hospital 2, although the evaluation of medi-
cal patients predominated (41.3%), followed by surgical 
patients (31.6%), there was a significantly higher per-
centage of assessments of neurosurgical (13.4%) and 
trauma patients (13.7%). The nursing workload was 
higher in Hospital 1, where in most cases each nurse 
takes care of more than two patients. With regard to 
the physicians’ workload, it was significantly higher 
in Hospital 1. It is in this centre that most frequently 
a physician treats more than three patients (36%). In 
terms of patient severity on the day of the administra-
tion of the AASTRE, the only differences found were 
in the SOFA subgroup <4 (more prevalent in Hospital 
1, 67.1%) and in the SOFA subgroup 4–7 (more preva-
lent in Hospital 2, 32.7%). Finally, in respect of length 
of stay in the ICU on the day of the AASTRE, in Hos-
pital 1 there was a significant predominance of patients 
whose length of stay was less than seven days (54%), the 
rest of the periods considered were significantly more 
prevalent in Hospital 2 except the period of ≥21 days, 
which was virtually identical in both hospitals.
Structure indicators
Perception of safety culture: The response rate to the 
perception of safety culture questionnaire that had been 
administered to 71 professionals was 94.4% (in the initial 
period), 66.6% (in the intermediate period) and 70.4% (in 
the final period). A progressive increase was observed in 
positive responses in the Safety Climate item throughout 
the study period (p < 0.0001) in the safety culture percep-
tion survey. No significant changes were observed in the 
other items (Table 3).
Implementation or updating of protocols and/or pro-
cedures: The use of the AASTRE was associated with 
changes in sedation/analgesia and weaning protocols 
at both hospitals. It is also noteworthy that in the two 
hospitals of the study, the use of AASTRE motivated 
the creation of a new procedure of the prescription and 
review of monitoring and mechanical ventilation (MV) 
alarms.
Process indicators
 The overall IPR-AASTRE-G were 6.7%. Table  4 shows 
the distribution of patients evaluated for each meas-
ure and improvement proportion related to the AAS-
TRE (IPR-AASTRE), and their evolution throughout 
the study period. Twelve of the 37 measures (32.4%) had 
IPR-AASTRE >10%. Some are included in the bundles to 
prevent VAP (evaluation of the level of sedation and pain 
in the sedated patient, semi-recumbent position) and 
CRB (daily assessment of catheter needs); others in the 
good medical practice guidelines (verification of alveo-
lar pressure in patients with acute respiratory failure, 
assessment of acute renal failure and artificial nutrition) 
and in the basic safety measures (appropriate treatment 
prescription, review of MV or monitor alarms, patient 
identification).
Table 3 Safety culture survey results in Hospital 2
NS no significant differences











Atmosphere in place of work 74.5 67.4 73.4 NS
Relations with colleagues 64.2 59.8 60.9 NS
Organization and management of the service and the hospital 40.8 35.5 42.2 NS
Safety climate 58.3 61.1 69.8 p < 0.0001
Work conditions 45.6 37.9 49.5 NS
Recognition of stress level 49.4 43.9 47.3 NS
Total 56.1 53.8 60.2 p = 0.005
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Block 1. Mechanical ventilation
 1. Alveolar pressure 
limit
124 (26.6) 71 (26.8) 20 (45.0) 33 (15.2) 0.12
 2. Mechanical ventila-
tion alarms
398 (31.2) 155 (34.2) 119 (33.6) 124 (25.0) 0.001
 3. Tolerance to sponta-
neous ventilation
175 (1.1) 59 (1.7) 56 (0.0) 60 (1.7) 0.62
 4. Suitable current 
volume
336 (1.5) 17 (2.6) 107 (0.9) 112 (0.9) 0.47
Block 2. Haemodynamics
 5. Monitor alarms 557 (21.5) 223 (23.3) 142 (23.9) 192 (17.7) <0.0001
 6. Water balance and 
fluid adjustment
557 (1.1) 223 (0.5) 142 (0.7) 192 (2.8) 0.36
 7. Adequate haemody-
namic monitoring
556 (0.4) 223 (0.0) 141 (0.7) 192 (0.5) 0.49




93 (1.1) 40 (0.0) 19 (0.0) 34 (2.9) 0.41
Block 3. Renal function and CRRT
 9. Acute renal failure 
assessment
654 (11.8) 280 (14.6) 160 (10.6) 214 (8.9) 0.03
 10. CRRT treatment 
prescription
27 (3.7) 13 (0.0) 6 (0.0) 8 (12.5) 0.29
 11. CRRT monitoring 28 (0.0) 14 (0.0) 6 (0.0) 8 (0.0) Not calculable
Block 4. Sedation/analgesia
 12. Evaluation of seda-
tion level and pain of 
sedated patient
199 (11.6) 86 (15.1) 61 (9.8) 52 (7.7) 0.30
 13. Pain assessment in 
non-sedated patient
396 (8.6) 137 (13.1) 110 (5.5) 149 (6.7) 0.19
 14. Oversedation pre-
vention
132 (9.8) 65 (10.8) 42 (2.4) 25 (20.0) 0.16
Block 5. Treatment (1)
 15. Check drug allergies 
and intolerances in 
patient’s medical 
history
623 (4.8) 268 (4.1) 161 (6.8) 194 (1.6) 0.10
 16. Correct prescription 
of daily treatment 
orders
623 (4.8) 268 (5.6) 161 (4.9) 194 (3.6) 0.66
 17. Adequate indication 
and dosage of the 
prescribed medica-
tion
622 (3.9) 268 (4.9) 160 (3.8) 194 (2.6) 0.37




623 (1.9) 268 (3.4) 161 (0.0) 194 (1.6) <0.0001
Block 6. Treatment (2)
 19. Prevention of 
thromboembolic 
disease
549 (4.9) 249 (7.2) 146 (3.4) 154 (2.6) 0.04















 20. Prophylaxis of 
gastrointestinal 
haemorrhage
587 (0.3) 266 (0.4) 159 (0.0) 162 (0.6) 0.63
 21. Control of hypergly-
caemia
588 (1.4) 264 (1.5) 160 (1.3) 164 (1.2) 0.85
 22. Assessment of the 
antibiotic treatment
436 (2.3) 195 (3.1) 119 (0.8) 122 (2.5) 0.43
 23. Appropriate transfu-
sion
554 (0.2) 233 (0.0) 157 (0.6) 164 (0.0) 0.49
Block 7. Techniques and tests
 24. Checking of X-ray 
slides
539 (1.5) 186 (1.6) 165 (2.4) 188 (0.5) 0.34
 25. Daily assessment of 
the need for catheters
624 (16.8) 225 (16.0) 183 (19.7) 216 (15.3) 0.46
Block 8. Nutrition
 26. Monitoring of 
enteral nutrition
487 (24.6) 241 (27.0) 117 (27.4) 129 (17.8) 0.11
 27. Daily assessment by 
parenteral nutrition 
team
78 (23.1) 24 (4.2) 25 (24.0) 29 (37.9) 0.04
Block 9. Nursing care
 28. Verification of 
endotracheal tube 
cuff pressure
436 (0.5) 195 (0.0) 127 (0.8) 114 (0.9) 0.58
 29. Oral hygiene 
with chlorhexidine 
(0.12–0.2%)
476 (0.4) 217 ((0.5) 138 (0.7) 121 (0.0) 0.52
 30. Daily assessment of 
the risk of developing 
pressure ulcers
563 (12.3) 282 (18.1) 151 (6.6) 130 (6.2) <0.0001
 31. Daily assessment 
of the protective 
measures for the 
safe handling of the 
patient
557 (1.1) 281 (1.1) 148 (1.4) 128 (0.8) 0.47
 32. Semi-recumbent 
position
433 (21.7) 196 (20.9) 123 (24.4) 114 (20.2) 0.48
Block 10. Structure
 33. Unequivocal patient 
identification
594 (12.5) 243 (14.4) 190 (12.1) 161 (9.9) 0.42
 34. Patient clinical 
information properly 
structured in the 
medical history
592 (24.8) 243 (26.3) 189 (29.1) 160 (17.5) 0.06
 35. Life-sustaining 
treatment limit sheet 
updated
82 (9.8) 30 (10.0) 22 (4.5) 30 (13.3) 0.44
 36. Correct position of 
bed rails
584 (0.3) 240 (0.8) 185 (0.0) 159 (0.0) 0.24
 37. Information to fam-
ily members
592 (0.2) 242 (0.4) 189 (0.0) 161 (0.0) 0.46
CRRT continuous renal replacement techniques
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Only six steps (verification of MV or monitor alarms, 
proper administration of the prescribed treatment, 
assessment of acute renal failure and the risk of devel-
oping pressure ulcers and prevention of thromboem-
bolic disease) showed a progressive decrease in the 
IPR-AASTRE throughout the study period. In addition, 
in one measure (“daily assessment by parenteral nutri-
tion team”), a significant increase was seen in IPR-AAS-
TRE as it was assessed during the different four-month 
periods.
Table  5 shows the impact of the independent vari-
ables selected (type of patient, staffing ratio, severity and 
length of stay) in the IPR-AASTRE-B. The high PNR was 
associated with a higher IPR-AASTRE in the MV and 
haemodynamics blocks. The SOFA was associated inde-
pendently with a higher IPR-AASTRE-B in four blocks. 
Finally, the length of stay was significantly inversely asso-
ciated with the IPR-AASTRE-B of the techniques and 
tests and treatment blocks.
Outcome indicators
The use of the AASTRE was associated with a significant 
decline in the VAP rate. No significant impact on average 
stay, mortality and CRB rate was observed (Table 6).
Discussion
Checklists have been proposed as tools to ensure that 
essential components of care are not omitted [15]. 
However, this is the first multicentre study to analyse 
the impact of real-time random safety audits on qual-
ity indicators in the critical patient. An improvement is 
seen in indicators of structure (safety climate, clinical 
protocols and healthcare procedures), process (better 
adherence to good clinical practice guidelines) and out-
come (decline in the rate of VAP) [16]. These data sup-
port a way to improve health care for the critical patient 
by means of the AASTRE tool whose use is feasible as 
shown in the pilot study published previously by our 
group [10].
Table 5 Variables related to the utility of the AASTRE (multivariate analysis)
CRRT continuous renal replacement techniques













Mechanical ventilation 2.6 (1.1–6.7) 0.9 (0.7–1.0) 1.4 (1.1–1.7) 1.1 (1.0–1.4) 0.9 (073–1.0)
Haemodynamics 2.9 (1.2–7.4) 0.9 (0.6–1.3) 0.9 (0.7–1.3) 0.9 (0.8–1.2) 0.9 (0.8–1.2)
Renal function/CRRT 0.3 (0.0–1.4) 0.9 (0.6–1.4) 2.0 (1.5–2.5) 1.1 (0.9–1.4) 0.9 (0.8–1.1)
Sedation and analgesia 0.9 (0.2–3.5) 0.9 (0.5–1.3) 1.2 (0.8–1.7) 1.0 (0.8–1.3) 0.9 (0.7–1.1)
Treatment 1 0.5 (0.1–2.7) 1.4 (0.9–2.0) 1.4 (1.1–1.8) 0.9 (0.8–1.1) 0.8 (0.6–0.9)
Treatment 2 1.5 (0.2–11.1) 1.5 (0.9–2.5) 1.1 (0.8–1.7) 0.9 (0.7–1.3) 0.6 (0.4–0.8)
Techniques and tests 1.3 (0.4–3.6) 0.6 (0.4–1.9) 0.9 (0.7–1.2) 0.9 (0.8–1.2) 0.7 (0.5–0.9)
Nutrition 0.5 (0.1–2.5) 1.2 (0.8–1.6) 0.9 (0.8–1.3) 1.1 (0.9–1.3) 0.9 (0.8–1.1)
Nursing care 1.2 (0.5–3.2) 1.1 (0.8–1.4) 1.4 (1.1–1.7) 0.9 (0.8–1.1) 0.9 (0.8–1.2)
Structure 1.0 (0.4–2.5) 1.0 (0.7–1.2) 1.2 (1.0–1.5) 1.1 (0.9–1.3) 0.9 (0.8–1.1)
Table 6 Outcome indicators
N number, VAP ventilator-associated pneumonia, MV mechanical ventilation, CRB central venous catheter-related bacteraemia , IDR incidence density ratio
Year Hospital 1 Hospital 2
2012 2013 p 2012 2013 p
Number of patients 967 1018 939 927
APACHE II 10.4 11.2 0.39 14.9 14.4 0.72
ICU average LOS (days) 3.3 4.0 0.09 7.7 7.9 0.07
ICU gross mortality (%) 4.0 5.1 19.0 16.1
ICU standardized mortality by APACHE 2012 (%) 4.0 4.3 0.23 19.0 16.5 0.15
VAP rate (No. of VAP episodes/1000 days MV) 4.2 0.9 7.9 4.0
IDR VAP2013/2012 (95% confidence interval) 0.2 (0.05–0.9) 0.02 0.5 (0.3–0.9) 0.03
CRB rate (No. of CRB episodes/1000 days of central venous catheter) 3.9 1.5 2.8 4.8
CRB IDR2013/2012 (95% confidence interval) 0.4 (0.1–1.2) 0.42 1.7 (0.7–3.9) 0.10
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Structure indicators
The use of the AASTRE was associated with an improve-
ment in the safety climate. An association has been 
described between a better safety climate and outcome 
[17], average stay [18] or adverse events [19]. Although 
other authors have not demonstrated that checklists 
improve communication and teamwork [20], the impact 
of the AASTRE on the safety climate could be the result 
of improved communication in clinical practice, as 
described in other tools [21].
The guidelines require local adaptation via local pro-
tocols to enable their effective, safe and efficient use [22, 
23]. The AASTRE were associated with the need to renew 
sedation/analgesia and weaning protocols. This occurs as 
a natural consequence when verifying the safety meas-
ures using AASTRE reflexively and at the bedside. This 
highlights the need to update local protocols in accord-
ance with the latest sources of scientific knowledge. Dif-
ficulties for adherence have been described [24, 25] in 
both protocols. The AASTRE allow evaluating adherence 
to protocols and can promote their regular updating. The 
AASTRE have improved safety in relation to monitoring 
and mechanical ventilation alarms through the creation 
of specific protocols.
While the beneficial effect of the introduction of pro-
tocols in clinical practice has been discussed [26, 27], 
most studies acknowledge that they are useful although 
more patently in hands of inexperienced healthcare pro-
viders or suboptimal work environments. In such mal-
functioning environments, they help but may hinder the 
performance and progress of the health professional, 
reducing their autonomy [28]. In fact, in a study pub-
lished recently, no effect of the protocols was observed 
in the outcome [29]. Therefore, AASTRE promote much 
needed professional autonomy but invites reflection as to 
decisions at the bedside. And this reflection leads to the 
updating of protocols even though a direct improvement 
in the results is not guaranteed.
Process indicators: IPR-AASTRE
Health care requires many more scientifically sound pro-
cess measures than are currently available. The AASTRE 
are process indicators since they evaluate the degree of 
adherence to scientific evidence [30]. They allow measur-
ing the gap between the indication of therapies that have 
proven effective within human clinical research and the 
real safe and effective use of these therapies in routine 
clinical practice.
The failure to ensure that patients receive recom-
mended medical care is supported by high-quality clini-
cal research evidence. This type of safety and quality 
problem can be effectively addressed with knowledge 
translation tools [23].
The fact that 12 of the 37 measures considered (32.4%) 
had IPR-AASTRE >10% shows the ability of the AAS-
TRE to modify essential aspects of clinical practice and 
improve adherence to evidence-based guidelines, a 
priority in health care [11, 23, 31]. Hopefully, through 
organizational learning, this effect could be maintained 
over time [32]. In this regard, some authors [33] have 
described the ability of checklists to maintain adherence 
to good clinical practice guidelines achieving close to 
100% compliance for semi-recumbent position or suit-
able sedation. However, in our study, these measures 
scored IPR-AASTRE of 21.7 and 11.6%, indicating that if 
the intervention (AASTRE) had not been implemented, 
the measure would not have been carried out in a large 
percentage of patients. Also, the evaluation of another 
essential measure as is the assessment of catheter needs, 
in our experience, was corrected in 16.8% of evalua-
tions. The fact that IPR-AASTRE utility is maintained 
over time may be related to the complexity of ICU clini-
cal activity. In this regard, the AASTRE act as a tool that 
redirects healthcare activity towards essential aspects of 
care, regardless of the environmental situation. However, 
in our study six measures showed a significant decrease 
along the four-month periods analysed, indicating that 
this tool can also help systematize healthcare and organi-
zational learning. Nevertheless, in the case of measures 
with a gradually ascending IPR-AASTRE, it should be 
verified (as occurs in this study with the measure “daily 
assessment by parenteral nutrition team”) that the lack 
of adherence to the recommendations can be accounted 
for by causes from outside the work team implement-
ing AASTRE (a problem of communication with other 
agents involved in treating the patient, as might occur in 
this case with professionals of the Pharmacy Service who 
are responsible for monitoring hospital parenteral nutri-
tion, for example).
The AASTRE have proven to be more effective in more 
serious patients, in the early days of admission and in 
increased workload environments. These findings are 
consistent with the data published by our group previ-
ously [11]. Without interrupting the work flow, aspects of 
severe patient care are recalled and their definitive inclu-
sion into treatment is left to the discretion of the senior 
physician responsible of the patient, according to the 
indication:risk ratio.
Outcome indicators
The concept of care bundling and its efficacy in improv-
ing clinical outcomes are also supported in the literature 
[34]. Our results show a significant decrease in VAP 
influencing three of the recommendations established to 
prevent this type of adverse event (assessment of seda-
tion level, semi-recumbent position and prophylaxis of 
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deep venous thrombosis). Dubose et  al. [35] described 
this effect at a trauma ICU through a checklist of VAP 
bundle measures. However, in our study, the AASTRE 
had no impact on mortality and CRB. Probably, to dem-
onstrate an impact on the rate of CRB requires influ-
encing other aspects such as catheter insertion and 
maintenance [36].
In the critical patient, no study has managed to associ-
ate the use of safety checklists with a decrease in mortal-
ity [15]. Recently, in a study of Brazilian ICUs [37], the 
introduction of daily checklists, goal setting and clini-
cian prompting did not decrease in-hospital mortality 
or other clinical outcomes. Despite being a study with a 
considerable sample size, some organizational and meth-
odological aspects could render the results unreproduc-
ible outside that environment. For example, the health 
system is not comparable to the European one as regards 
cultural aspects and the organization of work teams. 
Moreover, standardized mortality is high and the num-
ber of patients recruited in each ICU was relatively low. 
In addition, important methodological aspects such as 
the period of analysis (just 4  months in that study), the 
definition of the measures, the eligibility of the patients 
and training in the use of the tools are different in the 
two studies. Nevertheless, the most distinguishing factor 
between the studies is the role of the prompter. Accord-
ing to the authors of the Brazilian study, the feedback of 
the clinician with the prompter was carried out later in 
the day. In our study, this is one of the keys of our meth-
odology, the prompter interacts at the bedside during 
healthcare activity, immediately after the daily clinical 
rounds, acting as a catalyser of the transfer of knowl-
edge, thus improving adherence to scientific proof. In any 
case, we are aware that a single intervention, albeit cross-
cutting, never has a definitive impact on patient progno-
sis. Moreover, using mortality as an outcome measure 
requires larger samples and risk adjustment for fair com-
parison among providers and organizations [38].
There are limitations to this study. (1) Only two ICUs 
have participated. Moreover, their participation in the 
design of the AASTRE tool, the experience gained by 
the research team from the pilot study and the develop-
ment of the culture of the continuous improvement of 
the quality of care that is underlying in the participating 
centres may mean that it is not possible to extrapolate the 
results to other ICUs. (2) The Hawthorne effect, a per-
formance gain resulting from the knowledge of being 
observed, is difficult to distinguish from those resulting 
from the intervention. (3) The perception of safety cul-
ture was investigated only at one centre. (4) Sample size 
was not initially calculated to investigate the impact of 
the AASTRE on mortality or nosocomial infection rates. 
(5) The study design does not include a control group, 
since the random selection of the patients evaluated in 
the safety audits does not allow this. (6) Having demo-
graphic data of the patient populations attended to dur-
ing the study period, of the quantitative evaluation of the 
Nursing workload and of the incidence of adverse events 
may have helped establish more precise analysis of the 
data and of the impact of AASTRE (Additional file 1).
Conclusions
In conclusion, our results suggest that the AASTRE were 
associated with improved structure, process and out-
come indicators. In addition, this tool allows simultane-
ously translating medical evidence to clinical practice, 
reducing errors of omission, and also allows assessing 
quality through process indicators.
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